FACSLyric 663518Recalls & reported problems

Summary

The FDA's MAUDE database contains 65 adverse event reports that list this exact device (DI 00382906635181), received between Aug 4, 2020 and Oct 15, 2025 — classified as 65 malfunctions.

The most frequently reported specific device problem is “Contamination” (37 reports).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

1. Nov 1, 2024Class IIOpen, Classified

   On October 18, 2024, BD has identified through customer complaints and an increase in field failures / replacements of the power supply module (part number 650781, Power Module AC-DC 250W 12/24V M3S4S6) on BD FACSLyric flow cytometers, which has the potential for the instruments to fail to power on and/or stay on. The potential power supply failure on BD FACSLyric Flow Cytometer may lead to risks to the laboratory staff including inhalation of fumes followed by shortness of breath or coughing if failure occurs during laboratory working hours. The patient may be asked to return for additional biospecimen collection procedure and risks associated with the procedure (bruising, pain, bleeding, etc.). In addition, patient specimen loss and/ or delay providing results of testing results. There may be additional risks to the laboratory staff including inhalation of fumes followed by shortness of breath or coughing if failure occurs during laboratory working hours. In addition, the patient may be asked to return for additional biospecimen collection procedure and risks associated with the procedure (bruising, pain, bleeding, etc.). In the Notification Letter sent on November 20, 2024, customers are instructed to continue their normal operation of your BD FACSLyric Flow Cytometer according to the Instructions For Use after immediately inspecting inventory for the specific catalog and power supply serial numbers listed in the notification letter and follow the instructions listed under Actions for Clinical Users.

   Z-0749-2025 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗

Most reported problems

Recent adverse event reports

The 25 most recent of 65 reports, in the reporter's own words as published by the FDA.

• MalfunctionOct 15, 2025Contamination; Contamination

  IT WAS REPORTED THAT CARRYOVER WAS OBSERVED ON PATIENT SAMPLES DURING USE WITH THE BD FACSLYRIC¿. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CONTAMINATION: 1. WERE PATIENT SAMPLES CONTAMINATED OR WAS THERE CARRYOVER (CROSS-CONTAMINATION/MIXING) BETWEEN PATIENT SAMPLES? IF NO, NO FURTHER QUESTIONS REQUIRED. PATIENT SAMPLES CONTAMINATED, CARRYOVER BETWEEN PATIENT SAMPLES, UNKNOWN - GO TO QUESTION #2. CARRYOVER BETWEEN PATIENT SAMPLES. 2. PLEASE DESCRIBE ANY ADDITIONAL DETAILS: GO TO PATIENT SAMPLES CHECKLIST. CUSTOMER NOTICED CARRYOVER AFTER SEEING THE SECOND TUBE ACQUIRE. CUSTOMER STOPPED ACQUISITION AND CONTACTED FOR SERVICE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23304691 ↗
• MalfunctionJul 3, 2025Contamination; Contamination

  IT WAS REPORTED THAT DURING USE WITH BD FACSLYRIC¿ FLOW CYTOMETER CARRYOVER INVOLVING PATIENT SAMPLES OCCURRED. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM CHINESE TO ENGLISH: LARGE SAMPLE RESIDUE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 22399344 ↗
• MalfunctionApr 23, 2025Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING BD FACSLYRIC¿ IT FAILED TO PULL AWAY ASPIRATION COMPLETELY DURING SIT FLUSH CAUSING CARRY OVER BETWEEN SAMPLES. NO PATIENT INJURIES WERE REPORTED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WASTE IS NOT BEING PULLED AWAY COMPLETELY. MACHINE FAILED TO PULL AWAY ASPIRATION DURING SIT FLUSH CAUSING CARRY OVER BETWEEN SAMPLES.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21892324 ↗
• MalfunctionApr 2, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT CARRYOVER BETWEEN PATIENT SAMPLES WAS OBSERVED AFTER USAGE OF BD FACSLYRIC¿ . THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: SPOKE WITH CUSTOMER AND THEY ARE GETTING LASER DELAY SETUP ERRORS DURING PQC. THEY HAVE COMPLETED A FEW LONG CLEANS IN THE LAST FEW WEEKS BECAUSE THEY ARE STILL HAVING SOME CARRYOVER ISSUES BETWEEN SAMPLES. SYSTEM HAS BEEN HAVING ISSUES WITH CARRYOVER, CLEANING THE SYSTEM CLEARS UP THE ISSUE BUT IT COMES BACK AFTER A FEW DAYS. NO RESULTS WERE USED IF CARRYOVER WAS PRESENT.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21756073 ↗
• MalfunctionMar 21, 2025Contamination; Contamination

  IT WAS REPORTED THAT CARRYOVER WAS OBSERVED DURING USE OF THE BD FACSLYRIC¿. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED BY THE CUSTOMER THAT CD4 NOT FALLING WITHIN RANGE ON SEVERAL OCCASIONS FOR MULTITEST NORM CONTROL (349701). CONTAMINATION: 1. WERE PATIENT SAMPLES CONTAMINATED OR WAS THERE CARRYOVER (CROSS-CONTAMINATION/MIXING) BETWEEN PATIENT SAMPLES? IF NO, NO FURTHER QUESTIONS REQUIRED. PATIENT SAMPLES CONTAMINATED, CARRYOVER BETWEEN PATIENT SAMPLES, UNKNOWN - GO TO QUESTION #2. CARRY OVER BETWEEN PATIENT SAMPLES. 2. PLEASE DESCRIBE ANY ADDITIONAL DETAILS: GO TO PATIENT SAMPLES CHECKLIST. SMALL AMOUNT OF CARRYOVER BETWEEN SAMPLES. IS THERE A SPECIFIC REASON FOR CHECKING THE ASSAY MULTIPLE TIMES? IS IT FAILING THE FIRST TIME AND IT IS BEING RECHECKED? OUR PROCESS IS TO RUN MULTICHECK CONTROLS (NORMAL AND LOW) FOR BOTH ASSAYS (3/8/45/4 AND TBNK) ON BOTH LYRICS. FROM TIME TO TIME, ONE OF THEM WILL FAIL ON ONE LYRIC BUT PASS ON THE OTHER, WHICH SPEAKS TO THE POINT THAT IT¿S NOT THE TUBE, BUT THE INSTRUMENT RUN. SO THEN WE RE-RUN THE FAILED QC ON THE FIRST LYRIC AND IT COMES ¿IN¿ ON THE RE-RUN. WHEN THERE IS A FAILURE, IS THE TUBE VORTEXED BEFOR

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21665345 ↗
• MalfunctionFeb 20, 2025Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT DURING USE WITH BD FACSLYRIC¿ CARRYOVER INVOLVING PATIENT SAMPLES OCCURRED. THERE WAS NO IMPACT TO PATIENT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER CALLED IN STATING THAT THEY ARE EXPERIENCING CARRYOVER FROM 1 TUBE TO THE NEXT TUBE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 21421496 ↗
• MalfunctionJun 20, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT DURING USE OF BD FACSLYRIC¿ CARRYOVER WAS OBSERVED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CONTAMINATION: 1. WERE PATIENT SAMPLES CONTAMINATED OR WAS THERE CARRYOVER (CROSS-CONTAMINATION/MIXING) BETWEEN PATIENT SAMPLES? CARRYOVER BETWEEN PATIENT SAMPLES. CUSTOMER PROBLEM: SYSTEM IS HAVING ISSUES WITH CARRYOVER BETWEEN CELLS.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 19579314 ↗
• MalfunctionJun 14, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT CARRYOVER WAS OBSERVED IN PATIENT SAMPLES DURING USE WITH THE BD FACSLYRIC¿. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: WERE PATIENT SAMPLES CONTAMINATED OR WAS THERE CARRYOVER (CROSS-CONTAMINATION/MIXING) BETWEEN PATIENT SAMPLES? CARRYOVER BETWEEN PATIENT SAMPLES. PLEASE DESCRIBE ANY ADDITIONAL DETAILS: GO TO PATIENT SAMPLES CHECKLIST. SPOKE WITH CUSTOMER AND SHE TOLD ME THEY ARE HAVING ISSUES WITH CARRYOVER BETWEEN SAMPLES WHEN USING THE MANUAL MODE. THAT IS WHY THEY PLACED CALL. SYSTEM WILL NOT BE USED UNTIL SERVICED. SYSTEM IS HAVING CARRYOVER ISSUES.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 19537791 ↗
• MalfunctionMay 23, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT CARRYOVER WAS OBSERVED DURING USE WITH THE BD FACSLYRIC¿. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: AFTER JUST RECENTLY DISCUSSING WITH ACCOUNT HERE ARE THE CURRENT CONCLUSIONS: 1) THERE SEEMED TO BE ONE PATIENT AFFECTED, ACCOUNT CALLED YESTERDAY AFTERNOON FOR CARRYOVER ISSUES AT END OF DAY.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 19382696 ↗
• MalfunctionApr 26, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT DURING USE WITH BD FACSLYRIC¿ FLOW CYTOMETER CARRYOVER OCCURRED ON PATIENT SAMPLES. THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: THE CUSTOMER REPORTS THAT THEY ARE SEEING TRUCOUNT BEADS CARRYING OVER INTO SUBSEQUENT SAMPLES INTERMITTENTLY. ALSO, THEIR ABSOLUTE COUNTS WHEN RUN ON MULTIPLE TUBES ARE OFF. DID CARRYOVER HAPPENED ON PATIENT SAMPLES? "YES" THEY ARE SEEING TRUCOUNT BEAD CARRY OVER IN PATIENT SAMPLES.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 19192684 ↗
• MalfunctionApr 10, 2024Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT WHILE USING BD FACSLYRIC¿ FLOW CYTOMETER CONTAMINATION OF A PATIENT SAMPLE OCCURRED. THERE WAS NO REPORT OF USER IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER. "IT WAS REPORTED BY CUSTOMER THAT SIT DRIPPING." ¿MDR SAFETY CHECKLIST : CONTAMINATION : 1. WERE SAMPLES CONTAMINATED? (IF NO, NO FURTHER QUESTIONS REQUIRED. IF YES OR UNKNOWN, GO TO PATIENT SAMPLES CHECKLIST): YES. MDR SAFETY CHECKLIST : PATIENT SAMPLES 1. ARE THERE ERRONEOUS RESULTS ON PATIENT SAMPLES FROM DIAGNOSTIC TEST? (IF YES OR UNKNOWN, GO TO QUESTION #2. IF NO, NO FURTHER QUESTIONS REQUIRED.): YES. 2. WAS THERE ANY DELAY OF TREATMENT DUE TO THE ISSUE? (GO TO QUESTION #3): NO. 3. IF PATIENT SAMPLES WERE REDRAWN, WAS THERE ANY CHANGE OR DELAY OF TREATMENT? (GO TO QUESTION #4): NOT APPLICABLE. 4. WAS THERE ANY PHYSICAL HARM/INJURY TO THE PATIENT DUE TO THE ISSUE? (IF YES OR UNKNOWN, GO TO QUESTION #5. IF NO, NO FURTHER QUESTIONS REQUIRED): NO.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 19080227 ↗
• MalfunctionSep 12, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT ERRONEOUS RESULTS WERE OBSERVED DURING USE WITH THE BD FACSLYRIC¿. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IF THERE WAS ANY CONTAMINATION THAT INVOLVES PATIENT SAMPLE? NO CONTAMINATION REPORTED; WERE ERRONEOUS RESULTS OBSERVED ON PATIENT SAMPLES? AFTER THE USER RE-RAN THE SAMPLE IN MANUAL MODE, THE CORRECT SAMPLE DATA WAS ACQUIRED; WHETHER CARRYOVER HAPPENED ON PATIENT SAMPLES? NO CARRYOVER WAS REPORTED. IT WAS REPORTED BY THE CUSTOMER THAT THE INSTRUMENT LOST EVENTS/POPULATIONS IN ONE TUBE'S ACQUISITION ON THE SAMPLE RACK, WHILE THE OTHER TUBES RAN JUST FINE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 17730846 ↗
• MalfunctionJun 29, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ THAT THERE WERE ERRONEOUS RESULTS. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CONTAMINATION: 1. WERE SAMPLES CONTAMINATED? (IF NO, NO FURTHER QUESTIONS REQUIRED. IF YES, GO TO PATIENT SAMPLES CHECKLIST). YES. POTENTIAL IMPACT TO PATIENT SAMPLES/DATA QUESTIONS: 1. ARE THERE ERRONEOUS RESULTS ON PATIENT SAMPLES FOR DIAGNOSTIC TEST? (IF YES, GO TO QUESTION #2, IF NO, NO FURTHER QUESTIONS REQUIRED.) YES. 2. WAS THERE ANY DELAY OF TREATMENT DUE TO THE ISSUE? (GO TO QUESTION #3). NO. 3. IF PATIENT SAMPLES WERE REDRAWN, WAS THERE ANY CHANGE OR DELAY OF TREATMENT? (GO TO QUESTION #4). NO. 4. WAS THERE ANY PHYSICAL HARM/INJURY TO THE PATIENT DUE TO THE ISSUE? (IF YES, GO TO QUESTION #5. IF NO, NO FURTHER QUESTIONS REQUIRED). NO. SIT FLUSH DRIPS ¿ PINCHED TUBING.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 17234768 ↗
• MalfunctionJun 5, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ THAT THERE WAS CARRY OVER INVOLVING PATIENT SAMPLES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: (B)(6): (B)(6) 2023 15:21:56 (GMT). DID ANY LIQUID LEAKAGE OR SPLASH OR SPRAY COME INTO CONTACT WITH EYES OR MOUTH OR ANY MUCOUS MEMBRANE OR NON-INTACT (BROKEN) SKIN? IF NO, STOP - NO FURTHER QUESTIONS REQUIRED. NO PATIENT CARRYOVER.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 17066191 ↗
• MalfunctionJun 5, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT WHILE USING BD FACSLYRIC¿ THAT THERE WAS CARRYOVER INVOLVING PATIENT SAMPLES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: PATIENT CARRYOVER.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 17066076 ↗
• MalfunctionJun 5, 2023Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ THAT THERE WAS CARRY OVER INVOLVING PATIENT SAMPLES. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: 1. DID ANY LIQUID LEAKAGE OR SPLASH OR SPRAY COME INTO CONTACT WITH EYES OR MOUTH OR ANY MUCOUS MEMBRANE OR NON-INTACT (BROKEN) SKIN? IF NO, STOP - NO FURTHER QUESTIONS REQUIRED. NO. PATIENT CARRYOVER.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 17059094 ↗
• MalfunctionApr 26, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING BD FACSLYRIC¿ THAT THERE WAS CARRYOVER INVOLVING PATIENT SAMPLES.THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER:CUSTOMER BELIEVES THERE IS CARRYOVER AND WAITING FOR A BD ACTION, WE CAN NOT JUST MOVE TO EP THEN CLOSE EP BEFORE CLOSING THE LOOP WITH THE CUSTOMER. CLINICAL APPS STILL NEEDS TO DETERMINE IF CARRYOVER IS PRESENT- FIELD SERVICE DOES NOT COMPLETE THIS.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16817183 ↗
• MalfunctionFeb 27, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ THAT THERE WAS A CARRYOVER ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER THAT THEY ARE SEEING EXTRA POPULATIONS, POSSIBLE CARRYOVER ISSUE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16448817 ↗
• MalfunctionFeb 21, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ THAT THERE WAS A CARRYOVER ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CARRYOVER ISSUE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16409465 ↗
• MalfunctionFeb 21, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ THAT THERE WAS A CARRYOVER ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CARRYOVER ISSUE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16409461 ↗
• MalfunctionFeb 8, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ THAT THERE WAS A CARRY OVER ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CARRYOVER ISSUE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16328064 ↗
• MalfunctionFeb 8, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ 3L12C INSTRUMENT THAT THERE WAS SAMPLE CARRYOVER ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED BY THE CUSTOMER THAT THERE WAS A SAMPLE CARRY OVER ISSSUE. CARRYOVER ISSUE WHEN RUNNING SAMPLE.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16320163 ↗
• MalfunctionFeb 3, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ 3L12C INSTRUMENT THAT THERE WAS SAMPLE CARRYOVER ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED BY THE CUSTOMER THAT THERE WAS A SAMPLE CARRY OVER ISSSUE. LAB REPORTING EXCESS AMOUNT OF SAMPLE CARRY OVER FROM ONE TUBE TO ANOTHER DURING SAMPLES RUN.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16294459 ↗
• MalfunctionFeb 3, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ 3L12C INSTRUMENT THAT THERE WAS CARRYOVER. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER IT WAS REPORTED BY THE CUSTOMER THAT THERE WAS A SAMPLE CARRYOVER ISSUE. LAB REPORTING EXCESS AMOUNT OF SAMPLE CARRY OVER FROM ONE TUBE TO ANOTHER DURING SAMPLES RUN.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16294458 ↗
• MalfunctionFeb 3, 2023Contamination; Contamination

  IT WAS REPORTED THAT WHILE USING THE BD FACSLYRIC¿ 3L12C INSTRUMENT THAT THERE WAS SAMPLE CARRYOVER ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: IT WAS REPORTED BY THE CUSTOMER THAT THERE WAS A SAMPLE CARRY OVER ISSSUE. LAB REPORTING EXCESS AMOUNT OF SAMPLE CARRY OVER FROM ONE TUBE TO ANOTHER DURING SAMPLES RUN.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 16294456 ↗